[HTML][HTML] Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects

…, RH Reynolds, E Yu, K Senkevich, U Rudakou… - Nature …, 2022 - nature.com
Rapid-eye movement (REM) sleep behavior disorder (RBD), enactment of dreams during
REM sleep, is an early clinical symptom of alpha-synucleinopathies and defines a more …

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin

K Senkevich, U Rudakou, Z Gan-Or - Neuropharmacology, 2022 - Elsevier
Parkinson's disease (PD) is defined as a complex disorder with multifactorial pathogenesis,
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …

Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies

…, L Ferini‐Strambi, A Heidbreder, U Rudakou… - Annals of …, 2020 - Wiley Online Library
Objective The TMEM175/GAK/DGKQ locus is the 3rd strongest risk locus in genome‐wide
association studies of Parkinson disease (PD). We aimed to identify the specific disease‐…

GBA variants in REM sleep behavior disorder: A multicenter study

L Krohn, JA Ruskey, U Rudakou, E Leveille… - Neurology, 2020 - AAN Enterprises
Objective To study the role of GBA variants in the risk for isolated REM sleep behavior disorder
(iRBD) and conversion to overt neurodegeneration. Methods A total of 4,147 individuals …

Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease

E Yu, U Rudakou, L Krohn, K Mufti… - Movement …, 2021 - Wiley Online Library
Background Biallelic PRKN mutation carriers with Parkinson's disease (PD) typically have
an earlier disease onset, slow disease progression, and, often, different neuropathology …

Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations

U Rudakou, E Yu, L Krohn, JA Ruskey, F Asayesh… - Brain, 2021 - academic.oup.com
Genome-wide association studies (GWAS) have identified numerous loci associated with
Parkinson’s disease. The specific genes and variants that drive the associations within the vast …

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease

K Senkevich, CE Zorca, A Dworkind, U Rudakou… - Brain, 2023 - academic.oup.com
The association between glucocerebrosidase, encoded by GBA, and Parkinson’s disease (PD)
highlights the role of the lysosome in PD pathogenesis. Genome-wide association …

Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease

P Saini, U Rudakou, E Yu, JA Ruskey, F Asayesh… - Neurobiology of …, 2021 - Elsevier
Rare mutations in genes originally discovered in multigenerational families have been
associated with increased risk of Parkinson's disease (PD). The involvement of rare variants in …

Age at onset of Parkinson's disease among Ashkenazi Jewish patients: contribution of environmental factors, LRRK2 p. G2019S and GBA p. N370S mutations

…, S Israeli-Korn, L Krohn, U Rudakou… - Journal of …, 2020 - content.iospress.com
Background: Both genetic and environmental factors contribute to Parkinson’s disease (PD)
risk. Objective: We investigated the potential association of several relevant variables with …

Common and rare GCH1 variants are associated with Parkinson's disease

U Rudakou, BOA Bencheikh, JA Ruskey, L Krohn… - Neurobiology of …, 2019 - Elsevier
GCH1 encodes the enzyme guanosine triphospahte (GTP) cyclohydrolase 1, essential for
dopamine synthesis in nigrostriatal cells, and rare mutations in GCH1 may lead to Dopa-…